| Financial Year |
March 31 2023 |
| Monetary Funds |
14,785,134,321.38 |
| Held-for-trading Financial Assets |
3,323,819,437.58 |
| Notes Receivable |
73,821,000.00 |
| Accounts Receivable |
11,478,803,644.39 |
| Advances to Suppliers |
685,319,970.13 |
| Other Receivables |
553,219,377.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,598,292,672.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
103,648,896.04 |
| Other Current Assets |
2,227,178,581.89 |
| Total Current Assets |
40,728,059,596.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
9,110,443.63 |
| Long-term Equity Investment |
1,475,668,447.38 |
| Investment Properties |
-- |
| Fixed Assetes |
16,503,205,580.92 |
| Under-construction Projects |
10,049,229,332.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,927,970,925.17 |
| R&D expenses |
747,087,044.71 |
| Goodwill |
512,038,244.65 |
| Long-Term Deferred and Prepaid Expenses |
101,164,623.46 |
| Deferred Income Tax Assets |
853,325,345.58 |
| Other Non-Current Assets |
3,291,419,145.75 |
| Sub-Total of Non-Current Assets |
38,036,519,562.72 |
| Total Assets |
78,764,579,158.85 |
| Short-Term Loans |
10,661,062,756.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,714,353,271.46 |
| Accounts Payable |
11,559,733,707.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
179,871,432.77 |
| Taxes Payable |
119,152,099.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,088,661,997.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,318,729,875.20 |
| Other Current Liabilities |
129,972,025.64 |
| Sub-Total of Current Liabilities |
37,865,973,998.18 |
| Long-term Loans |
12,980,450,409.58 |
| Bonds Payable |
394,791,091.61 |
| Long-Term Accounts Payable |
1,899,454,828.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
386,388,113.30 |
| Deferred Income Tax Liabilities |
118,126,386.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,201,544,172.32 |
| Total Liabilities |
54,067,518,170.50 |
| Paid-In Capital(Or Share Stock) |
1,778,874,835.00 |
| Capital Surplus |
18,281,819,975.49 |
| Surplus Reserve |
188,051,476.38 |
| LESS:Treasury Stock |
404,574,459.45 |
| Undistributed Profits |
3,621,926,016.41 |
| Minority Stockholder's Interest |
1,016,339,005.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,680,721,983.30 |
| Owner's Equity（Stockholder's Equity） |
24,697,060,988.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
78,764,579,158.85 |
